Loading...

VOR VOR BIOPHARMA INC Management Changes 8-K Filing

VR B

VR

VOR BIOPHARMA INC

(VOR)

2025 8-K

Show Summary

Show Summary

Equity Offerings

Workforce Reduction

Noncompliance with Listing ...

Management Change

Stock Option Repricing

Board Appointment

Private Placement

Clinical Data Update

CFO Appointment

Resignation and Appointment

Equity Incentive Plan Amend...

Appointment of Director

Clinical Update

Annual Meeting of Stockholders

Resignation of Director

Clinical Update

External Links:

Eyal C. Attar, M.D. resigned as Chief Medical Officer of Vor Biopharma Inc. effective April 18, 2025, to pursue a new opportunity, and will provide transition services under a consulting agreement.

AI Assistant

VOR BIOPHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.